BNP Paribas Financial Markets’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$731 Sell
138
-138
-50% -$731 ﹤0.01% 4368
2025
Q1
$1.22K Buy
276
+8
+3% +$35 ﹤0.01% 4206
2024
Q4
$1.87K Sell
268
-157
-37% -$1.1K ﹤0.01% 4168
2024
Q3
$6.17K Buy
425
+263
+162% +$3.82K ﹤0.01% 3100
2024
Q2
$11.8K Sell
162
-872
-84% -$63.6K ﹤0.01% 3029
2024
Q1
$61.2K Sell
1,034
-2,965
-74% -$176K ﹤0.01% 2883
2023
Q4
$293K Buy
3,999
+2,713
+211% +$199K ﹤0.01% 2375
2023
Q3
$50K Buy
1,286
+675
+110% +$26.2K ﹤0.01% 2789
2023
Q2
$35.3K Buy
611
+549
+885% +$31.7K ﹤0.01% 2915
2023
Q1
$4.06K Sell
62
-76
-55% -$4.97K ﹤0.01% 2965
2022
Q4
$3.81K Buy
138
+87
+171% +$2.4K ﹤0.01% 3023
2022
Q3
$1.49K Sell
51
-1,217
-96% -$35.5K ﹤0.01% 3664
2022
Q2
$24.3K Buy
1,268
+1,148
+957% +$22K ﹤0.01% 3041
2022
Q1
$9.74K Sell
120
-329
-73% -$26.7K ﹤0.01% 3232
2021
Q4
$41.1K Buy
449
+191
+74% +$17.5K ﹤0.01% 3128
2021
Q3
$32.2K Buy
258
+195
+310% +$24.4K ﹤0.01% 3003
2021
Q2
$7.15K Sell
63
-114
-64% -$12.9K ﹤0.01% 3181
2021
Q1
$26.8K Sell
177
-106
-37% -$16.1K ﹤0.01% 3150
2020
Q4
$32.5K Sell
283
-47
-14% -$5.4K ﹤0.01% 3073
2020
Q3
$25.5K Buy
330
+258
+358% +$20K ﹤0.01% 3126
2020
Q2
$7.88K Sell
72
-330
-82% -$36.1K ﹤0.01% 3180
2020
Q1
$43.9K Buy
402
+141
+54% +$15.4K ﹤0.01% 2997
2019
Q4
$41.4K Buy
261
+75
+40% +$11.9K ﹤0.01% 3075
2019
Q3
$27.4K Buy
186
+28
+18% +$4.13K ﹤0.01% 3169
2019
Q2
$18.4K Sell
158
-68
-30% -$7.92K ﹤0.01% 3299
2019
Q1
$24.4K Buy
+226
New +$24.4K ﹤0.01% 3254
2018
Q4
Hold
0
3603